Pfizer's long range vaccine pursuits pay off
By LINDA A. JOHNSON Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid first-quarter performance across most of the company, hiked its 2021 financial forecas…
By LINDA A. JOHNSON Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid first-quarter performance across most of the company, hiked its 2021 financial forecas…